Ryodai Yamamura, PhD

  • 1Article
  • 7KReads
  • 2022Active
  • 7Collaborators
  • 5Citations

About

Ryodai Yamamura, PhD is affiliated with Division of Biomedical Oncology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. Ryodai Yamamura has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2022. Their work focuses on Schizophrenia/Schizoaffective Disorders.

Publications

JCP
Differences Among Second-Generation Antipsychotics in Effects on HbA1c
Original Research

Differences Among Second-Generation Antipsychotics in Effects on HbA1c

March 30, 2022

The antipsychotic blonanserin was associated with less change in glycated hemoglobin (HbA1c) levels than olanzapine, and changes in BMI were lower for both blonanserin and aripiprazole. Study results indicate...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe